Trial of Mirtazapine for Depression in IBD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Trial of Mirtazapine for Depression in IBD — Stella

Recruiting

Back to Major Depressive Disorder trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United Kingdom

Guy's and St Thomas' Hospital NHS Foundation Trust, London

Imperial College Healthcare NHS Trust, London

King's College Hospital NHS Foundation Trust, London

St Mark's Hospital, London

Key details

Phase

Safety & dosing

Sponsor

King's College London

Collaborators

King's College Hospital NHS Trust, Imperial College London

Enrollment target

~76 participants

Started

May 2024

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 125 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov